Track insider transactions across markets
| 30 days | 90 days | 120 days | |
|---|---|---|---|
| Average return | -1% | 8.2% | 15.1% |
| Success rate | 48% | 68% | 82% |
| Transactions |
22
27% Buy
|
34
71% Buy
|
47
69% Buy
|
| Position | Company | Period |
|---|---|---|
| Chief Financial Officer, Chief Operating Officer, Senior Vice President | Nektar Therapeutics | Oct. 1, 2019 - |
| Independent Director | Rezolute Inc | Nov. 20, 2019 - |
| Director | Rezolute Inc | Oct. 9, 2017 - Nov. 20, 2019 |
| Chief Financial Officer, Senior Vice President | Nektar Therapeutics | June 2, 2016 - Oct. 1, 2019 |
| Senior Vice President, General Counsel, Secretary | Nektar Therapeutics | April 2, 2007 - June 2, 2016 |
Search